Cargando…
Identification of ACKR4 as an immune checkpoint in pulmonary arterial hypertension
OBJECTIVE: Inflammation is recognized as a contributor in the development of pulmonary arterial hypertension (PAH), and the recruitment and functional capacity of immune cells are well-orchestrated by chemokines and their receptors. This study is aimed at identification of critical chemokines in the...
Autores principales: | Jiang, Chen-Yu, Wu, Li-Wei, Liu, Yi-Wei, Feng, Bei, Ye, Lin-Cai, Huang, Xu, He, Yang-Yang, Shen, Yi, Zhu, Yi-Fan, Zhou, Xing-Liang, Jiang, Dai-Ji, Qi, Hai-Kun, Zhang, Hao, Yan, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337759/ https://www.ncbi.nlm.nih.gov/pubmed/37449198 http://dx.doi.org/10.3389/fimmu.2023.1153573 |
Ejemplares similares
-
D6/ACKR2
por: Graham, Gerard J.
Publicado: (2015) -
The Duffy Antigen Receptor for Chemokines DARC/ACKR1
por: Horuk, Richard
Publicado: (2015) -
Prospects for targeting ACKR1 in cancer and other diseases
por: Crawford, Kyler S., et al.
Publicado: (2023) -
ACKR2: An Atypical Chemokine Receptor Regulating Lymphatic Biology
por: Bonavita, Ornella, et al.
Publicado: (2017) -
Corrigendum: ACKR2: An Atypical Chemokine Receptor Regulating Lymphatic Biology
por: Bonavita, Ornella, et al.
Publicado: (2017)